Episode Summary In this episode, Shafi discusses his decades-long journey and what led him into the world of statistical programming. He shares insights into the evolution of automation in clinical trials, its role in transforming traditional tasks like validation and double programming, and the impact AI is having on oversight and traceability for large teams. Shafi also addresses the ongoing challenges in scaling AI for clinical trial reporting and how embracing these technologies is critical for staying ahead in the evolving landscape of the industry. Biography Shafi Shafi has been a programmer in the pharmaceutical industry for 30 years and holds an MSc. in Statistics. After working for CROs and Pharma companies across Europe, he founded Shafi Consultancy in 2001 to support statistical programming from their offices in the UK and Bangladesh. Shafi is driven by helping others to become skilled programmers and by innovating to improve process efficiency in the industry. To this end, his team has developed training videos and applications for Risk-Based Monitoring, Visualisation and automation of clinical programming activities in Metalytics, that auto-generates programs and removes the mundane, routine and repetitive tasks. Shafi believes that an open discussion of ideas helps the industry to continuously develop and has been a regular presenter at industry conferences like Phuse, PSI and PAGE for almost 20 years. Resources Learn more about us: https://www.verisian.com/ Join the Verisian Community: https://www.verisian.com/community Follow us on LinkedIn: https://www.linkedin.com/company/verisian/

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related